image
Healthcare - Medical - Devices - NYSE - US
$ 80.32
2.1 %
$ 11 B
Market Cap
107.09
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one GMED stock under the worst case scenario is HIDDEN Compared to the current market price of 80.3 USD, Globus Medical, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one GMED stock under the base case scenario is HIDDEN Compared to the current market price of 80.3 USD, Globus Medical, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one GMED stock under the best case scenario is HIDDEN Compared to the current market price of 80.3 USD, Globus Medical, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
2.52 B REVENUE
60.62%
166 M OPERATING INCOME
24.67%
103 M NET INCOME
-16.19%
521 M OPERATING CASH FLOW
113.82%
-176 M INVESTING CASH FLOW
-58.11%
-27.7 M FINANCING CASH FLOW
88.05%
657 M REVENUE
5.05%
60.3 M OPERATING INCOME
25.32%
51.8 M NET INCOME
63.21%
204 M OPERATING CASH FLOW
275.34%
-15 M INVESTING CASH FLOW
-44.22%
19.6 M FINANCING CASH FLOW
124.86%
Balance Sheet Globus Medical, Inc.
image
Current Assets 2.18 B
Cash & Short-Term Investments 890 M
Receivables 558 M
Other Current Assets 730 M
Non-Current Assets 3.07 B
Long-Term Investments 0
PP&E 612 M
Other Non-Current Assets 2.46 B
Current Liabilities 856 M
Accounts Payable 75.1 M
Short-Term Debt 10.2 M
Other Current Liabilities 771 M
Non-Current Liabilities 551 M
Long-Term Debt 527 M
Other Non-Current Liabilities 23.9 M
EFFICIENCY
Earnings Waterfall Globus Medical, Inc.
image
Revenue 2.52 B
Cost Of Revenue 0
Gross Profit 2.52 B
Operating Expenses 1.14 B
Operating Income 166 M
Other Expenses 63 M
Net Income 103 M
RATIOS
100.00% GROSS MARGIN
100.00%
6.59% OPERATING MARGIN
6.59%
4.09% NET MARGIN
4.09%
2.47% ROE
2.47%
1.96% ROA
1.96%
3.21% ROIC
3.21%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Globus Medical, Inc.
image
Net Income 103 M
Depreciation & Amortization 253 M
Capital Expenditures -115 M
Stock-Based Compensation 54.2 M
Change in Working Capital 0
Others 236 M
Free Cash Flow 405 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Globus Medical, Inc.
image
Wall Street analysts predict an average 1-year price target for GMED of $76.9 , with forecasts ranging from a low of $60 to a high of $100 .
GMED Lowest Price Target Wall Street Target
60 USD -25.30%
GMED Average Price Target Wall Street Target
76.9 USD -4.31%
GMED Highest Price Target Wall Street Target
100 USD 24.50%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Globus Medical, Inc.
image
Sold
0-3 MONTHS
1.47 M USD 2
3-6 MONTHS
28 M USD 5
6-9 MONTHS
70 K USD 1
9-12 MONTHS
6.35 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Jan 10, 2025
Sell 1.1 M USD
Pfeil Keith W
COO, CFO
- 12501
88.17 USD
1 month ago
Jan 10, 2025
Sell 149 K USD
Pfeil Keith W
COO, CFO
- 1666
89.17 USD
3 months ago
Dec 02, 2024
Sell 218 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2500
87.0006 USD
3 months ago
Nov 21, 2024
Sell 1.12 M USD
Davidar David D
Director
- 13234
85 USD
3 months ago
Nov 22, 2024
Sell 575 K USD
Davidar David D
Director
- 6766
85.0037 USD
3 months ago
Nov 21, 2024
Sell 1.13 M USD
Davidar David D
Director
- 13254
85 USD
3 months ago
Nov 22, 2024
Sell 573 K USD
Davidar David D
Director
- 6746
85.0037 USD
3 months ago
Nov 22, 2024
Sell 93.3 K USD
Lemaitre Dan
Director
- 1097
85.0166 USD
3 months ago
Nov 21, 2024
Sell 1.13 M USD
Lemaitre Dan
Director
- 13278
85 USD
3 months ago
Nov 21, 2024
Sell 11 M USD
Scavilla Daniel T
President, CEO
- 130000
85 USD
3 months ago
Nov 06, 2024
Sell 4.8 M USD
Scavilla Daniel T
President, CEO
- 60000
80.02 USD
3 months ago
Nov 06, 2024
Sell 200 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2500
80.02 USD
3 months ago
Nov 06, 2024
Sell 205 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2500
82 USD
4 months ago
Oct 16, 2024
Sell 563 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 7500
75.0199 USD
4 months ago
Oct 16, 2024
Sell 2.25 M USD
Davidar David D
Director
- 30000
75.0401 USD
4 months ago
Oct 16, 2024
Sell 1.5 M USD
Davidar David D
Director
- 20000
75.0305 USD
5 months ago
Sep 13, 2024
Sell 1.06 M USD
RHOADS ANN D
Director
- 15000
70.36 USD
5 months ago
Sep 13, 2024
Sell 1.76 M USD
Davidar David D
Director
- 25000
70.46 USD
7 months ago
Jul 11, 2024
Sell 70 K USD
Norwalk Leslie V
Director
- 1000
70 USD
9 months ago
May 10, 2024
Sell 4.09 M USD
Lemaitre Dan
Director
- 63300
64.6133 USD
9 months ago
May 08, 2024
Sell 1.3 M USD
Davidar David D
Director
- 20000
65 USD
11 months ago
Mar 15, 2024
Sell 551 K USD
Norwalk Leslie V
Director
- 10590
51.99 USD
1 year ago
Mar 01, 2024
Sell 236 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 4385
53.79 USD
1 year ago
Mar 01, 2024
Sell 170 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 3115
54.53 USD
1 year ago
May 15, 2023
Sell 2.48 M USD
Lemaitre Dan
Director
- 43450
56.9845 USD
2 years ago
Feb 02, 2023
Sell 2.26 M USD
Pfeil Keith W
SVP, Chief Financial Officer
- 29167
77.568 USD
3 years ago
Aug 19, 2021
Sell 63.4 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
76.13 USD
2 years ago
Dec 01, 2022
Sell 563 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 7500
75.0001 USD
2 years ago
Apr 19, 2022
Sell 2.46 M USD
Davidar David D
director:
- 31500
78.034 USD
2 years ago
Apr 08, 2022
Sell 189 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2500
75.585 USD
2 years ago
Mar 15, 2022
Sell 579 K USD
TOBIN JAMES R
director:
- 8850
65.471 USD
2 years ago
Mar 08, 2022
Sell 323 K USD
TOBIN JAMES R
director:
- 4484
72 USD
2 years ago
Mar 10, 2022
Sell 700 K USD
TOBIN JAMES R
Director
- 10000
70.0398 USD
3 years ago
Aug 19, 2021
Sell 63.4 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
76.13 USD
3 years ago
Aug 02, 2021
Sell 69.3 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
83.24 USD
3 years ago
Jul 19, 2021
Sell 65.3 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 834
78.25 USD
3 years ago
Jul 02, 2021
Sell 7.81 M USD
Scavilla Daniel T
EVP, Chief Commercial Officer
- 99600
78.41 USD
3 years ago
Jul 02, 2021
Sell 31.6 K USD
Scavilla Daniel T
EVP, Chief Commercial Officer
- 400
78.97 USD
3 years ago
Jul 01, 2021
Sell 64.5 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
77.43 USD
3 years ago
Jun 25, 2021
Sell 2.06 M USD
Pfeil Keith W
SVP, Chief Financial Officer
- 27479
75.04 USD
3 years ago
May 10, 2021
Sell 1.8 M USD
TOBIN JAMES R
Director
- 25000
71.96 USD
3 years ago
May 05, 2021
Sell 377 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 5021
75 USD
3 years ago
Apr 23, 2021
Sell 8.68 M USD
Demski David M
President, CEO
- 121259
71.59 USD
3 years ago
Apr 26, 2021
Sell 10.3 M USD
Demski David M
President, CEO
- 144263
71.5 USD
3 years ago
Mar 09, 2021
Sell 961 K USD
Lemaitre Dan
Director
- 15384
62.47 USD
4 years ago
Dec 28, 2020
Sell 132 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2000
66.15 USD
4 years ago
Dec 16, 2020
Sell 3.36 M USD
Demski David M
President, CEO
- 52356
64.2 USD
4 years ago
Dec 17, 2020
Sell 10.6 M USD
Demski David M
President, CEO
- 164719
64.2 USD
4 years ago
Aug 06, 2020
Sell 5.37 M USD
Demski David M
President, CEO
- 96900
55.42 USD
4 years ago
Aug 06, 2020
Sell 3.83 M USD
Demski David M
President, CEO
- 68100
56.24 USD
4 years ago
Aug 06, 2020
Sell 9.41 M USD
Demski David M
President, CEO
- 165000
57.02 USD
4 years ago
Nov 24, 2020
Sell 1.92 M USD
Davidar David D
Director
- 32000
60 USD
4 years ago
Nov 24, 2020
Sell 600 K USD
Davidar David D
Director
- 10000
60 USD
4 years ago
Sep 02, 2020
Sell 318 K USD
TOBIN JAMES R
Director
- 5600
56.85 USD
4 years ago
Aug 25, 2020
Sell 947 K USD
TOBIN JAMES R
Director
- 17400
54.4 USD
4 years ago
Aug 24, 2020
Bought 33.1 K USD
Douglas Robert Andrew
Director
+ 615
53.88 USD
4 years ago
Aug 06, 2020
Sell 5.37 M USD
Demski David M
President, CEO
- 96900
55.42 USD
4 years ago
Aug 06, 2020
Sell 3.83 M USD
Demski David M
President, CEO
- 68100
56.24 USD
4 years ago
Aug 06, 2020
Sell 9.41 M USD
Demski David M
President, CEO
- 165000
57.02 USD
4 years ago
Aug 06, 2020
Sell 329 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 6000
54.78 USD
4 years ago
Aug 06, 2020
Sell 168 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 3000
55.92 USD
4 years ago
Aug 06, 2020
Sell 174 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 3000
57.9 USD
4 years ago
Jul 22, 2020
Bought 32.9 K USD
Douglas Robert Andrew
Director
+ 690
47.75 USD
4 years ago
Jun 22, 2020
Bought 33.7 K USD
Douglas Robert Andrew
Director
+ 700
48.2 USD
4 years ago
Jun 11, 2020
Sell 463 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 9076
51 USD
4 years ago
May 21, 2020
Sell 5.51 M USD
Scavilla Daniel T
EVP, Chief Commercial Officer
- 100000
55.09 USD
5 years ago
Dec 17, 2019
Sell 380 K USD
Huller Kelly
SVP, General Counsel
- 6460
58.9 USD
5 years ago
Nov 07, 2019
Sell 2.05 M USD
Davidar David D
Director
- 38000
54 USD
5 years ago
Nov 07, 2019
Sell 540 K USD
Davidar David D
Director
- 10000
54.04 USD
5 years ago
Nov 07, 2019
Sell 168 K USD
Huller Kelly
SVP, General Counsel
- 3000
55.9 USD
5 years ago
Nov 01, 2019
Sell 159 K USD
Huller Kelly
SVP, General Counsel
- 3000
52.9 USD
5 years ago
Aug 02, 2019
Sell 150 K USD
Huller Kelly
SVP, General Counsel
- 3000
49.9 USD
5 years ago
Aug 16, 2019
Sell 2.47 M USD
Davidar David D
Director
- 50000
49.3301 USD
5 years ago
Mar 28, 2019
Sell 146 K USD
Huller Kelly
SVP, General Counsel
- 3000
48.59 USD
5 years ago
Mar 06, 2019
Sell 387 K USD
Williams Anthony L
President
- 8386
46.14 USD
5 years ago
Mar 07, 2019
Sell 1.74 M USD
Williams Anthony L
President
- 37826
46.01 USD
6 years ago
Mar 05, 2019
Sell 7.8 M USD
Williams Anthony L
President
- 165870
47.05 USD
6 years ago
Feb 28, 2019
Sell 904 K USD
TOBIN JAMES R
Director
- 18800
48.1 USD
6 years ago
Feb 26, 2019
Sell 400 K USD
TOBIN JAMES R
Director
- 8500
47.06 USD
6 years ago
Feb 26, 2019
Sell 19.2 K USD
TOBIN JAMES R
Director
- 400
47.91 USD
6 years ago
Feb 28, 2019
Sell 437 K USD
TOBIN JAMES R
Director
- 9300
47.04 USD
6 years ago
Sep 26, 2018
Sell 168 K USD
Payne Steven
Chief Accounting Officer
- 3000
56 USD
6 years ago
Sep 24, 2018
Sell 5.47 M USD
Paul David C
Executive Chairman
- 101320
54.0126 USD
6 years ago
Sep 25, 2018
Sell 41 M USD
Paul David C
Executive Chairman
- 748845
54.6964 USD
6 years ago
Jul 17, 2018
Sell 362 K USD
Paul David C
Executive Chairman
- 6841
52.95 USD
6 years ago
Jun 25, 2018
Sell 453 K USD
Schwartz Eric
Senior VP and General Counsel
- 8444
53.638 USD
6 years ago
Jun 25, 2018
Sell 84.9 K USD
Schwartz Eric
Senior VP and General Counsel
- 1556
54.594 USD
6 years ago
Jun 11, 2018
Sell 6.75 M USD
Williams Anthony L
President
- 120267
56.1353 USD
6 years ago
Jun 11, 2018
Sell 79.6 K USD
Williams Anthony L
President
- 1400
56.872 USD
6 years ago
May 31, 2018
Sell 1.16 M USD
Payne Steven
Chief Accounting Officer
- 20771
55.8096 USD
6 years ago
Apr 26, 2018
Sell 2.27 M USD
Paul David C
Executive Chairman
- 43750
51.8068 USD
6 years ago
Apr 26, 2018
Sell 18.8 M USD
Paul David C
Executive Chairman
- 363284
51.8068 USD
6 years ago
Apr 27, 2018
Sell 1.51 M USD
Paul David C
Executive Chairman
- 29066
51.7831 USD
6 years ago
Apr 30, 2018
Sell 3.78 M USD
Paul David C
Executive Chairman
- 72938
51.8053 USD
6 years ago
Apr 18, 2018
Sell 454 K USD
Demski David M
Chief Executive Officer
- 8899
51.0001 USD
6 years ago
Apr 19, 2018
Sell 1.47 M USD
Demski David M
Chief Executive Officer
- 28863
51 USD
6 years ago
Apr 13, 2018
Sell 155 K USD
Demski David M
Chief Executive Officer
- 3043
51 USD
6 years ago
Apr 09, 2018
Sell 911 K USD
Scavilla Daniel T
Senior VP and CFO
- 18210
50.0017 USD
6 years ago
Apr 10, 2018
Sell 1.56 M USD
Scavilla Daniel T
Senior VP and CFO
- 31250
50 USD
6 years ago
Mar 28, 2018
Sell 1.2 M USD
Schwartz Eric
Senior VP and General Counsel
- 24000
50 USD
6 years ago
Mar 08, 2018
Sell 1.52 M USD
Davidar David D
Director
- 30000
50.5003 USD
7 years ago
Dec 15, 2017
Sell 121 K USD
Payne Steven
Chief Accounting Officer
- 3076
39.3019 USD
7 years ago
Dec 13, 2017
Sell 574 K USD
Williams Anthony L
President
- 15000
38.2994 USD
7 years ago
Dec 04, 2017
Sell 751 K USD
Davidar David D
Director
- 18461
40.655 USD
7 years ago
Nov 09, 2017
Sell 1.8 M USD
Murphy A Brett
Group President, Commerical Op
- 51449
35 USD
7 years ago
Nov 10, 2017
Sell 509 K USD
Murphy A Brett
Group President, Commerical Op
- 14551
35 USD
7 years ago
Sep 06, 2017
Sell 450 K USD
Murphy A Brett
President, Commerical Op
- 15000
29.9935 USD
7 years ago
Jun 05, 2017
Sell 516 K USD
Williams Anthony L
President
- 16153
31.941 USD
8 years ago
Aug 04, 2016
Sell 1.75 M USD
Murphy A Brett
Group President, Commerical Op
- 74700
23.3606 USD
8 years ago
Aug 05, 2016
Sell 772 K USD
Murphy A Brett
Group President, Commerical Op
- 32992
23.3936 USD
9 years ago
Jan 06, 2016
Sell 414 K USD
WHEELER KURT
Director
- 15045
27.5 USD
9 years ago
Jan 06, 2016
Sell 412 K USD
LIPTAK ROBERT
Director
- 15000
27.5 USD
9 years ago
Nov 16, 2015
Sell 129 K USD
Murphy A Brett
Group President, Commerical Op
- 5000
25.8 USD
9 years ago
May 28, 2015
Sell 79.7 K USD
Payne Steven
Chief Accounting Officer
- 3076
25.92 USD
9 years ago
Mar 18, 2015
Sell 35.7 M USD
Paul David C
Chief Executive Officer
- 1427079
25 USD
9 years ago
Mar 19, 2015
Sell 12.4 M USD
Paul David C
Chief Executive Officer
- 494921
25 USD
10 years ago
Feb 26, 2015
Sell 845 K USD
Demski David M
President and COO
- 32510
26 USD
10 years ago
Oct 31, 2014
Sell 888 K USD
Davidar David D
Senior VP, Operations
- 38500
23.06 USD
10 years ago
May 02, 2014
Sell 736 K USD
BARON RICHARD A
Senior VP and CFO
- 30000
24.52 USD
11 years ago
Mar 06, 2014
Sell 6.97 M USD
Demski David M
President and COO
- 269829
25.83 USD
11 years ago
Mar 06, 2014
Sell 39.9 K USD
Demski David M
President and COO
- 1500
26.61 USD
11 years ago
Mar 04, 2014
Sell 1.31 M USD
Davidar David D
Senior VP, Operations
- 52500
25 USD
11 years ago
Mar 04, 2014
Sell 562 K USD
Davidar David D
Senior VP, Operations
- 22500
25 USD
11 years ago
Feb 18, 2014
Sell 1.26 M USD
Davidar David D
Vice President, Operations
- 52500
24 USD
11 years ago
Feb 18, 2014
Sell 540 K USD
Davidar David D
Vice President, Operations
- 22500
24 USD
11 years ago
Jan 15, 2014
Sell 1.99 M USD
Demski David M
President and COO
- 96813
20.51 USD
11 years ago
Dec 31, 2013
Sell 64.5 K USD
Demski David M
President and COO
- 3187
20.25 USD
11 years ago
Dec 18, 2013
Sell 32.3 K USD
Demski David M
President and COO
- 1634
19.75 USD
11 years ago
Dec 19, 2013
Sell 383 K USD
Demski David M
President and COO
- 19412
19.75 USD
11 years ago
Dec 20, 2013
Sell 572 K USD
Demski David M
President and COO
- 28954
19.75 USD
11 years ago
Dec 06, 2013
Sell 484 K USD
LIPTAK ROBERT
Director
- 25000
19.36 USD
11 years ago
Dec 03, 2013
Sell 1.01 M USD
Davidar David D
Vice President, Operations
- 52500
19.25 USD
11 years ago
Dec 03, 2013
Sell 433 K USD
Davidar David D
Vice President, Operations
- 22500
19.25 USD
11 years ago
Nov 26, 2013
Sell 132 K USD
Demski David M
President and COO
- 6876
19.25 USD
11 years ago
Nov 27, 2013
Sell 586 K USD
Demski David M
President and COO
- 30447
19.25 USD
11 years ago
Oct 31, 2013
Sell 1.85 M USD
Demski David M
President and COO
- 100000
18.5 USD
11 years ago
Oct 31, 2013
Sell 215 K USD
Demski David M
President and COO
- 11179
19.26 USD
11 years ago
Nov 01, 2013
Sell 28.8 K USD
Demski David M
President and COO
- 1498
19.25 USD
11 years ago
Oct 31, 2013
Sell 869 K USD
Davidar David D
Vice President, Operations
- 47724
18.2 USD
11 years ago
Oct 31, 2013
Sell 372 K USD
Davidar David D
Vice President, Operations
- 20453
18.2 USD
11 years ago
Oct 31, 2013
Sell 82.7 K USD
Davidar David D
Vice President, Operations
- 4545
18.2 USD
11 years ago
Aug 22, 2013
Sell 718 K USD
Demski David M
President and COO
- 40000
17.95 USD
11 years ago
Aug 22, 2013
Sell 74.6 K USD
Demski David M
President and COO
- 4154
17.95 USD
11 years ago
Aug 22, 2013
Sell 53.8 K USD
Davidar David D
Vice President, Operations
- 2958
18.2 USD
11 years ago
Aug 23, 2013
Sell 33.1 K USD
Davidar David D
Vice President, Operations
- 1818
18.2 USD
11 years ago
Aug 22, 2013
Sell 23.1 K USD
Davidar David D
Vice President, Operations
- 1268
18.2 USD
11 years ago
Aug 23, 2013
Sell 14.2 K USD
Davidar David D
Vice President, Operations
- 779
18.2 USD
11 years ago
Aug 22, 2013
Sell 5.13 K USD
Davidar David D
Vice President, Operations
- 282
18.2 USD
11 years ago
Aug 23, 2013
Sell 3.15 K USD
Davidar David D
Vice President, Operations
- 173
18.2 USD
11 years ago
Jul 05, 2013
Sell 172 K USD
Davidar David D
Vice President, Operations
- 10000
17.15 USD
11 years ago
Jul 01, 2013
Sell 331 K USD
Davidar David D
Vice President, Operations
- 20000
16.56 USD
11 years ago
Jun 25, 2013
Sell 853 K USD
Davidar David D
Vice President, Operations
- 52500
16.25 USD
11 years ago
Jun 26, 2013
Sell 901 K USD
Davidar David D
Vice President, Operations
- 52500
17.1691 USD
11 years ago
Jun 25, 2013
Sell 366 K USD
Davidar David D
Vice President, Operations
- 22500
16.25 USD
11 years ago
Jun 26, 2013
Sell 386 K USD
Davidar David D
Vice President, Operations
- 22500
17.1691 USD
12 years ago
Aug 08, 2012
Sell 25.7 K USD
Payne Steven
Chief Accounting Officer
- 2305
11.16 USD
11 years ago
May 03, 2013
Sell 650 K USD
Demski David M
President and COO
- 40000
16.25 USD
11 years ago
Mar 11, 2013
Sell 213 K USD
Demski David M
President and COO
- 14225
15 USD
12 years ago
Feb 13, 2013
Sell 387 K USD
Demski David M
President and COO
- 25775
15 USD
12 years ago
Jan 30, 2013
Sell 400 K USD
Murphy A Brett
Executive VP, US Sales
- 31103
12.87 USD
12 years ago
Aug 08, 2012
Sell 8.98 M USD
Clarus Lifesciences I, L.P.
10 percent owner
- 804232
11.16 USD
12 years ago
Aug 08, 2012
Sell 8.98 M USD
WHEELER KURT
director, 10 percent owner:
- 804232
11.16 USD
12 years ago
Aug 08, 2012
Sell 33.9 M USD
Paul David C
Chief Executive Officer
- 3039385
11.16 USD
12 years ago
Aug 08, 2012
Sell 189 K USD
Murphy A Brett
Executive VP, US Sales
- 16910
11.16 USD
12 years ago
Aug 08, 2012
Sell 8.98 M USD
LIPTAK ROBERT
director, 10 percent owner:
- 804232
11.16 USD
12 years ago
Aug 08, 2012
Sell 1.1 M USD
Demski David M
President and COO
- 98957
11.16 USD
12 years ago
Aug 08, 2012
Sell 1.16 M USD
Davidar David D
Vice President, Operations
- 103809
11.16 USD
12 years ago
Aug 08, 2012
Sell 704 K USD
Davidar David D
Vice President, Operations
- 63076
11.16 USD
7. News
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips GMED's fourth-quarter 2024 performance reflects strong synergies from the NuVasive merger. zacks.com - 1 week ago
Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript Globus Medical, Inc. (NYSE:GMED ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Vik Chopra - Wells Fargo Matt Miksic - Barclays David Saxon - Needham & Company Jason Wittes - ROTH Shagun Singh - RBC Caitlin Cronin - Canaccord Genuity Craig Bijou - Bank of America Securities Matthew O'Brien - Piper Sandler Steve Lichtman - Oppenheimer Ryan Zimmerman - BTIG Matthew Blackman - Stifel Operator Welcome to the Globus Medical's Fourth Quarter and Full Year 2024 Earnings Call. This time, all lines will be on mute and a Q&A session will be held after the prepared remarks. seekingalpha.com - 1 week ago
Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 1 week ago
Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates Globus Medical (GMED) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.60 per share a year ago. zacks.com - 1 week ago
Globus Medical: Q4 Revenue Tops Forecast Medical technologies specialist Globus Medical (GMED 0.04%) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) of $0.84, exceeding the consensus forecast of $0.75, along with revenue that reached $657.3 million, topping expectations by $12.3 million. fool.com - 1 week ago
Globus Medical Reports Fourth Quarter and Full Year 2024 Results AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2024. globenewswire.com - 1 week ago
Globus Medical (GMED) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com - 2 weeks ago
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 weeks ago
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain? GMED is set to acquire all shares of Nevro in an all-cash transaction, unlocking new growth opportunities. zacks.com - 2 weeks ago
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Nevro Corp. (NYSE: NVRO) to Globus Medical, Inc. (NYSE: GMED). Under the terms of the proposed transaction, shareholders of Nevro will receive $5.85 in cash for each share of Nevro that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the. businesswire.com - 3 weeks ago
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced they have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the boards of directors of both companies, Globus Medical will acquire all shares of Nevro for $5.85 per share. The transaction represents a total equity value of approximately $250 million. globenewswire.com - 3 weeks ago
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 3 weeks ago
8. Profile Summary

Globus Medical, Inc. GMED

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 11 B
Dividend Yield 0.00%
Description Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Contact 2560 General Armistead Avenue, Audubon, PA, 19403 https://www.globusmedical.com
IPO Date Aug. 3, 2012
Employees 5000
Officers Mr. Brian J. Kearns Senior Vice President of Business Development & Investor Relations Ms. Kelly G. Huller Esq. Executive Vice President & General Counsel Mr. David C. Paul Co-Founder & Executive Chairman Mr. Daniel T. Scavilla President, Chief Executive Officer & Director Mr. Keith W. Pfeil Chief Financial Officer & Chief Operating Officer